J-GLOBAL ID:201501028031402643   Update date: Sep. 01, 2020

Muhammad Baghdadi

バグダーディー ムハンマド | Muhammad Baghdadi
Affiliation and department:
Homepage URL  (1): https://kaken.nii.ac.jp/d/r/60711570.ja.html
Research field  (1): Tumor diagnostics and therapeutics
Papers (31):
  • Muhammad Baghdadi, Kozo Ishikawa, Sayaka Nakanishi, Tomoki Murata, Yui Umeyama, Takuto Kobayashi, Yosuke Kameda, Hiraku Endo, Haruka Wada, Bjarne Bogen, et al. A role for IL-34 in osteolytic disease of multiple myeloma. Blood advances. 2019. 3. 4. 541-551
  • Muhammad Baghdadi, Hiraku Endo, Atsushi Takano, Kozo Ishikawa, Yosuke Kameda, Haruka Wada, Yohei Miyagi, Tomoyuki Yokose, Hiroyuki Ito, Haruhiko Nakayama, et al. High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers. Scientific Reports. 2018. 8. 1
  • Muhammad Baghdadi, Yui Umeyama, Naoki Hama, Takuto Kobayashi, Nanumi Han, Haruka Wada, Ken-ichiro Seino. Interleukin-34, a comprehensive review. Journal of leukocyte biology. 2018. 104. 5. 931-951
  • Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Yui Umeyama, Tsukasa Ataka, Haruka Wada, Yumiko Oyamada, Naoki Hyakushima, Ken-ichiro Seino. Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report. Inflammation and Regeneration. 2018. 38. 12
  • Naoki Hama, Nanumi Han, Muhammad Baghdadi, Ken-ichiro Seino. A new target of Immunotherapy, IL-34. Japan Research Association for Immunotherapy. 2018. 6. 3-6
MISC (1):
  • Muhammmad Baghdadi, Ken-ichiro Seino. Therapeutic potential of IL-34 in cancer treatment. Clinical Immunology & Allergology. 2018. 70. 4. 422-428
Books (3):
  • iPS細胞の安全・高品質な作製技術
    技術情報協会 2016 ISBN:9784861046292
  • Hematopoietic Differentiation of Human Pluripotent Stem Cells
    Springer 2015 ISBN:9789401773119
  • Cancer Immunology: A Translational Medicine Textbook
    Springer 2015 ISBN:9783662440056
Lectures and oral presentations  (7):
  • A potential role for interleukin-34 in immunotherapeutic resistance of cancer
    (The 16th Annual Meeting of Japan Research Association for Immunotherapeutics 2019)
  • がん治療抵抗性におけるIL-34の役割
    (第4回 AMEDがん若手研究者ワークショップ 2019)
  • 免疫学の医療への応用:腫瘍免疫における最新知見
    (第8回北海道免疫疾患談話会 2018)
  • Interleukin-34, がんの治療標的としての可能性
    (第14回北海道癌免疫制御研究会 2018)
  • IL-34 correlates with therapeutic resistance, disease progression, and poor survival in lung cancers
    (The 22nd Annual Meeting of Japanese Association of Cancer Immunology 2018)
Education (1):
  • 2009 - 2013 Hokkaido University Department of Medical Oncology
Professional career (1):
  • PhD (Hokkaido University Graduate School of Medicine)
Work history (3):
  • 2017/04 - 現在 Hokkaido University Institute for Genetic Medicine Lecturer
  • 2014/06 - 2017/03 Hokkaido University Institute for Genetic Medicine Assistant professor
  • 2013/04 - 2014/05 Hokkaido University Institute for Genetic Medicine Postdoctoral Researcher
Association Membership(s) (4):
The Japanese Association of Cancer Immunology (JACI) ,  The Japanese Society for Immunology (JSI) ,  The Japanese Cancer Association (JCA) ,  Japan Research Association for Immunotherapeutics
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page